Accessibility Menu
Autonomix Medical logo

Autonomix Medical

(NASDAQ) AMIX

Current Price$0.42
Market Cap$4.75M
Since IPO (2024)-100%
5 YearN/A
1 Year-79%
1 Month+14%

Autonomix Medical Financials at a Glance

Market Cap

$4.75M

Revenue (TTM)

$0.00

Net Income (TTM)

$17.24M

EPS (TTM)

$-4.09

P/E Ratio

-0.10

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$0.42

Volume

79,201.229

Open

$0.41

Previous Close

$0.42

Daily Range

$0.41 - $0.42

52-Week Range

$0.34 - $2.82

AMIX News

No articles available.

AMIX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Autonomix Medical

Industry

Healthcare Equipment and Supplies

Employees

11

CEO

Bradley A. Hauser

Headquarters

The Woodlands, 77380, US

AMIX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-189%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-10.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.75M

Shares Outstanding

11.41M

Volume

79.20K

Short Interest

0.00%

Avg. Volume

3.35M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$11.59M

EBITDA

$11.05M

Operating Cash Flow

$8.26M

Capital Expenditure

$14.00K

Free Cash Flow

$8.27M

Cash & ST Invst.

$9.14M

Total Debt

$0.00

Autonomix Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$4.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.75M

N/A

Market Cap/Employee

$949.26K

N/A

Employees

5

N/A

Net Income

$3.26M

-20.2%

EBITDA

$3.34M

-27.4%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$9.93M

-7.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.69%

N/A

Return on Invested Capital

-2.05%

N/A

Free Cash Flow

$2.98M

-29.1%

Operating Cash Flow

$2.97M

-29.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KALAKALA BIO, Inc.
$0.24-3.94%
FLGCFlora Growth Corp.
$7.79-32.14%
HSCSHeartSciences Inc.
$2.65+3.11%
AIMAIM ImmunoTech Inc.
$0.98+6.84%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.51-0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.67+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.37-0.05%
QQQInvesco QQQ Trust
$583.80-0.02%

Questions About AMIX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.